Phase 1/2 Open-Label, Single-Ascending-Dose Study of EN-374, a Helper-Dependent Adenoviral-Based Gene Therapy, in Participants with X-Linked Chronic Granulomatous Disease
Clinical Trial Grant
Administered By
Pediatrics, Transplant and Cellular Therapy
Awarded By
Ensoma, Inc.
Start Date
September 16, 2025
End Date
December 31, 2027
Administered By
Pediatrics, Transplant and Cellular Therapy
Awarded By
Ensoma, Inc.
Start Date
September 16, 2025
End Date
December 31, 2027